Hepatitis B

June 1, 2017June 1, 2017

Survey Reports Gaps in Hepatitis Testing and Monitoring Across European Union

Results from a European Centre for Disease Prevention and Control (ECDC) survey suggest that European Union/European Economic Area (EU/EEA) member states suffer from significant gaps in national testing policies and ... Read more

May 25, 2017May 25, 2017

FDA Reviewing Application for Opdivo Use in Hepatocellular Carcinoma, Often Caused by Hepatitis

Hepatitis B, Hepatitis C, News

The U.S. Food and Drug Administration (FDA) recently accepted a supplemental Biologics License Application (sBLA) to extend the use of Opdivo (nivolumab) to patients with hepatocellular carcinoma (HCC). People chronically infected with hepatitis ... Read more

May 9, 2017May 9, 2017

Newly Diagnosed Cases of Hepatitis Delta Virus Infection in US is Increasing

Hepatitis B, Hepatitis D, News

The number of people newly diagnosed with Hepatitis Delta virus (HDV) infection in the United States is increasing. Furthermore, the incidence of HDV co-infection among chronic Hepatitis B virus (HBV) patients ... Read more

May 4, 2017May 4, 2017

Eiger Files New Drug Application for Lambda as Hepatitis D Therapy, Starts Clinical Trials

Hepatitis B, Hepatitis D, News

Eiger BioPharmaceuticals has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for Lambda (pegylated interferon lambda 1a) as a treatment for the hepatitis ... Read more

April 27, 2017April 27, 2017

Gilead Sciences Presents New Data on HCV, HBV Treatment with Harvoni

Hepatitis B, Hepatitis C, News

Harvoni (ledipasvir/sofosbuvir) may become a potential treatment for children with chronic hepatitis C virus (HCV) infection and adults with hepatitis B virus (HBV), according to results of two clinical trials ... Read more

April 18, 2017April 18, 2017

RTT MolecularDX Launches Tests to Detect Drug-resistant Hepatitis Viruses

Hepatitis B, Hepatitis C, News

RTT MolecularDx recently announced the pre-market launch of new genotyping tests to detect the presence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus type 1 (HIV-1), and ... Read more

April 6, 2017April 6, 2017

ContraVir Reports New Mechanism of Action for Hepatitis B Virus Inhibitor CRV431

Hepatitis B, News

ContraVir Pharmaceuticals, a New Jersey-based biopharma company that develops and commercializes antiviral therapies, is providing new insights into the mechanism of action of its hepatitis B virus (HBV)-optimized cyclophilin inhibitor CRV431. ... Read more

April 4, 2017April 4, 2017

New Study Investigates Link Between Viral Hepatitis and Parkinson’s Disease

Hepatitis B, Hepatitis C, News

A new study reported that both hepatitis B and hepatitis C viral infections may be associated with an increased risk of developing Parkinson’s disease. The study was published in the journal Neurology, the ... Read more

March 30, 2017March 30, 2017

Report Defines Plan to Prevent 90,000 Hepatitis B and C Deaths in US by 2030

Hepatitis B, Hepatitis C, News

With better strategies on prevention, screening, treatment, and creative financing for medications, the U.S. could eradicate hepatitis B and C as public health problems, preventing nearly 90,000 deaths by 2030, according ... Read more

February 14, 2017February 14, 2017

EMA Committee Rules Favorably on VBI Vaccine for Hepatitis B

Hepatitis B, News

A committee of the European Union’s drug regulatory agency has given its blessing to Sci-B-Vac, a vaccine for hepatitis B developed by Massachusetts-based VBI Vaccines. The Committee for Medicinal Products for Human ... Read more